MoMe ARC® Patch
Remote Cardiac Monitoring
FDA Cleared (Aug 2025)Active
Key Facts
About InfoBionic.Ai
InfoBionic.Ai is a Boston-based private company, founded in 2015, that has developed a sophisticated AI-enabled remote cardiac monitoring platform called MoMe ARC®. The system combines interchangeable biosensors, advanced AI analytics, and a seamless IT infrastructure to support virtual cardiac telemetry for a wide range of patient acuity levels. Recognized as a gold standard in the field, the company targets cardiology practices, hospitals, and health systems seeking to improve the efficiency and quality of their remote monitoring services. Its recent FDA clearance for a patch-based sensor marks a significant step in its product evolution.
View full company profileTherapeutic Areas
Other Remote Cardiac Monitoring Drugs
| Drug | Company | Phase |
|---|---|---|
| Telemedicine Technology Development | ACS Diagnostics | Development |